NCT07789548

Brief Summary

Thyroidectomy is commonly associated with mild-to-moderate postoperative pain that may affect respiratory function and recovery. Bilateral intermediate cervical plexus block provides effective analgesia, but larger local anesthetic volumes may increase phrenic nerve spread and diaphragmatic dysfunction. Low-volume ultrasound-guided block may provide adequate analgesia while better preserving diaphragmatic function and postoperative respiratory performance

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for phase_4

Timeline
25mo left

Started Sep 2026

Typical duration for phase_4

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 21, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 27, 2026

Completed
29 days until next milestone

Study Start

First participant enrolled

September 25, 2026

Expected
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 25, 2028

1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

October 25, 2028

Last Updated

August 27, 2026

Status Verified

August 1, 2026

Enrollment Period

2 years

First QC Date

August 21, 2026

Last Update Submit

August 24, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in diaphragmatic excursion in patient undergoing thyroidectomy

    Ultrasound-measured diaphragmatic excursion (cm), assessed at baseline before block and at predefined postoperative time points, to compare the effect of low-volume versus standard-volume bilateral intermediate cervical plexus block on diaphragmatic function.

    Baseline before block, 30 minutes after block.4 hour after block

Secondary Outcomes (2)

  • Postoperative Pain Score visual analog scale (vas)

    Postoperative pain score PACU arrival (0 hour), 6 hour, 12 hour, and 24 hour postoperatively

  • Total opioid consumption in 24hr postoperative

    After 24hour PACu arrival

Study Arms (2)

Low-Volume Group

ACTIVE COMPARATOR

Ultrasound-guided bilateral intermediate cervical plexus block using 5 mL of bupivacaine0.5% .on each side.

Drug: Bupivacain only

Standard-Volume Group

ACTIVE COMPARATOR

Ultrasound-guided bilateral intermediate cervical plexus block using 10 mL of bupivacaine 0.25% . on each side.

Drug: Bupivacain only

Interventions

Bilateral intermediate cervical plexus block using ultrasound-guided bupivacaine 0.5% for low volume group

Low-Volume Group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult patients aged between 18 and 65 years.
  • Patients scheduled for elective thyroidectomy under general anesthesia.
  • American Society of Anesthesiologists (ASA) physical status I-II.
  • Both sexes will be included.
  • Patients able to understand the study protocol and provide written informed consent.

You may not qualify if:

  • Patient refusal.
  • Other endocrine diseases (as uncontrolled diabetes mellitus, adrenal disorders, pituitary disorders)
  • Known allergy or hypersensitivity to local anesthetics.
  • Coagulopathy or ongoing anticoagulant therapy contraindicating regional anesthesia.
  • Local infection at the site of needle insertion.
  • Preexisting diaphragmatic dysfunction or phrenic nerve palsy.
  • Significant chronic respiratory disease affecting pulmonary function (e.g., severe COPD, restrictive lung disease, uncontrolled asthma).
  • Morbid obesity (BMI ≥ 35 kg/m²).
  • Psychiatric or neurological diseases affecting respiratory muscles.
  • Previous neck surgery or anatomical deformity interfering with cervical plexus --block performance or diaphragmatic ultrasound assessment.
  • Pregnancy..

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Assiut main university hospital

Asyut, Egypt

Location

Study Officials

  • Mostafa S Samy, MD

    Assiut university faculty of medicine

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Ahmed A Abdelsalam, Master

CONTACT

Nashua F Abdelhafaz, MD

CONTACT

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Ultrasound-guided bilateral intermediate cervical plexus block with bupivacaine
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant lecturer

Study Record Dates

First Submitted

August 21, 2026

First Posted

August 27, 2026

Study Start (Estimated)

September 25, 2026

Primary Completion (Estimated)

September 25, 2028

Study Completion (Estimated)

October 25, 2028

Last Updated

August 27, 2026

Record last verified: 2026-08

Data Sharing

IPD Sharing
Will not share

Locations